Better Therapeutics, Inc.

Better Therapeutics, Inc. (Nasdaq: BTTX) is a prescription digital therapeutics company developing software-based treatments for cardiometabolic diseases, with an initial focus on type 2 diabetes. The company went public in 2021 through a business combination with Mountain Crest Acquisition Corp. II, a blank-check vehicle sponsored by Mountain Crest Capital LLC. The 10-Q filed with the SEC on August 20, 2021 reflects the company's early post-merger operating period as it advanced its lead prescription digital therapeutic through the FDA regulatory process. BTTX operates in the healthcare and digital health sector. Sign up at SpacDesk for full data on BTTX, including sponsor history, filing timelines, and deal analytics.